I.Executive Summary
Supermicro designs and builds servers, storage and full rack-scale data-center systems, and has become one of the largest builders of NVIDIA-based AI server racks. In fiscal 2026 (the year to 30 June 2026) revenue rose 77.8% to $39.06 billion, net income was $2.23 billion and diluted EPS was $3.26. Management guides fiscal 2027 revenue to $65–72 billion.
On headline multiples the stock looks cheap: about 4.1× consensus fiscal 2027 earnings and 0.45× sales. The value question is whether those earnings turn into cash, and so far they have not. Over the last five fiscal years SMCI reported $5.36 billion of cumulative net income and −$7.91 billion of cumulative free cash flow. The gap was filled with bank debt, convertible notes, new common stock and, in June 2026, $4.31 billion of mandatory convertible preferred stock. The governance record is also blemished: a 2020 SEC accounting settlement, a 2024 auditor resignation followed by months of delayed filings, and a 2026 export-control indictment of three individuals associated with the company.
SMCI is a fast-growing, thin-margin, capital-hungry business. If consensus earnings arrive and the market pays even 10–14× for them, the arithmetic implies a high return; the risk is that the earnings never turn into cash.
Our illustrative five-year projection takes the fiscal 2027–fiscal 2028 consensus as Years 1–2, then applies stated growth rates for Years 3–5 and an exit P/E of 10.0×–14.0×; the base case is the midpoint of the bear–bull range. That gives Year-5 values of $80 (bear), $106 (base) and $137 (bull), against today's $26.87: an implied return of about +31.5% a year in the base case (+24.5% to +38.5%). Discounted at 10% a year, the base case is worth $65.58 today, +144% versus the price. Today's price enters only the implied return; the Year-5 values change only when earnings estimates or the stated assumptions do. Evidence: Weak–moderate. The FY2028 consensus range is wide ($5.39–$8.57), and most of the return comes from a low starting multiple. *All values are Pathos's illustrative estimates for educational purposes, not price targets or recommendations.
II.Business Overview
What it sells. SMCI sells application-optimized servers and storage systems, complete liquid- or air-cooled racks, and more recently whole-data-center "Data Center Building Block Solutions" (DCBBS). It also sells subsystems such as motherboards, chassis and power supplies. Its fiscal 2026 portfolio included systems for NVIDIA's Blackwell and Blackwell Ultra platforms (GB300 NVL72, GB200 NVL72, HGX B300/B200), and it has announced support for NVIDIA's upcoming Vera Rubin platform. Manufacturing is in-house, in the US, Taiwan and the Netherlands. The company was founded in San Jose in 1993 by Charles Liang, who remains President, CEO and Chairman.
Who buys it. SMCI sold to more than 1,000 customers in over 100 countries in each of the last three fiscal years, but revenue is concentrated. One customer accounted for 28.1% of fiscal 2026 net sales, and the United States for 70.9% of revenue.
Who supplies it. One supplier accounted for 63.1% of total purchases in fiscal 2026 (64.4% in FY25, 65.4% in FY24). The 10-K does not name it. Given the GPU-centric product mix, it is widely assumed to be NVIDIA; that identification is our inference, not a company disclosure.
Competition. In its 10-K the company names global vendors (Cisco, Dell, Hewlett Packard Enterprise, Lenovo) and original design manufacturers (Foxconn, Quanta Computer, Wiwynn), which it says benefit from scale and very low-cost manufacturing.
Economics in one line. SMCI is a high-volume system integrator. Gross margins ran between 10.8% and 18.0% over the last five years, and each dollar of growth needs a lot of inventory and receivables.
III.Share Price & Valuation Multiples
Price as of Nasdaq close, 13 Nov 2026 · Fundamentals: FY2026 10-K| Metric | Value | Basis |
|---|---|---|
| Share price | $26.87 | Close, 13 Nov 2026 |
| 52-week range | $19.48 – $51.40 | Low 23 Mar 2026 · high 2 Jun 2026 (intraday) |
| Market capitalisation | $17.66B | 656.97M shares (10-K cover, 31 Jul 2026) × $26.87 |
| Enterprise value | $23.17B | Mkt cap + $8.72B debt + $4.31B preferred (liq. pref.) − $7.52B cash |
| P/E, trailing (GAAP) | 8.2× | FY26 diluted EPS $3.26 |
| P/E, trailing (non-GAAP) | 7.4× | FY26 non-GAAP diluted EPS $3.63 (excludes stock comp) |
| P/E, forward | 4.1× | FY27 consensus EPS $6.52 (18 analysts), likely non-GAAP |
| EV / EBITDA | 8.2× | FY26 op. income $2,770M + D&A $54M = $2,824M |
| EV / Adjusted EBITDA | 6.7× | Company-defined, adds back $412M stock comp: $3,447M |
| Price / Sales | 0.45× | FY26 revenue $39,063M (EV/Sales 0.60×) |
| Price / Book | 1.7× | Common equity $10.25B ($14.48B less $4.23B preferred); $15.61/share |
| Price / Free cash flow | n/m | FY26 FCF was −$6.97B; five-year cumulative −$7.91B |
| Dividend yield (common) | None | The company has never paid a common dividend |
The low multiples reflect the business model (thin margins, heavy working capital), the governance discount and cyclical risk around AI capital spending. The forward P/E depends on consensus figures that rose sharply after the August results: the fiscal 2027 consensus was reported at $3.35 thirty days before mid-September. On a GAAP basis, management guided first-quarter fiscal 2027 EPS to $0.89–0.98 per diluted share on revenue of $14.5–15.5 billion. For context only (not an input to our work), the mean analyst price target compiled by Yahoo Finance was $42.38 (16 analysts). Our enterprise value counts the preferred stock at its $4.31B liquidation preference. On an as-converted basis (130.7M extra shares at today's price) the equity would be worth about $32.3B.
IV.Five-Year Financial Record
Source: SMCI Forms 10-K (FY2022–FY2026); FY2027 range is management guidance from the 11 Aug 2026 results release, not a reported result. GM = gross margin.
| US$ millions, FY to 30 Jun | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 5,196 | 7,123 | 14,989 | 21,972 | 39,063 |
| Growth | 46.1% | 37.1% | 110.4% | 46.6% | 77.8% |
| Gross profit | 800 | 1,283 | 2,061 | 2,430 | 4,227 |
| Gross margin | 15.4% | 18.0% | 13.8% | 11.1% | 10.8% |
| Operating income | 335 | 761 | 1,211 | 1,253 | 2,770 |
| Operating margin | 6.5% | 10.7% | 8.1% | 5.7% | 7.1% |
| Net income | 285 | 640 | 1,153 | 1,049 | 2,230 |
| Net margin | 5.5% | 9.0% | 7.7% | 4.8% | 5.7% |
| Diluted EPS (split-adj.) | $0.53 | $1.14 | $1.92 | $1.68 | $3.26 |
| Stock-based compensation | 33 | 54 | 232 | 314 | 412 |
| Operating cash flow | (441) | 664 | (2,486) | 1,660 | (6,810) |
| Capital expenditure | (45) | (37) | (124) | (127) | (162) |
| Free cash flow | (486) | 627 | (2,610) | 1,532 | (6,972) |
| Diluted shares (wtd. avg., M) | 536.2 | 559.7 | 602.1 | 628.4 | 697.3 |
Fiscal 2026 by quarter: an uneven year
| US$ millions | Q1 (Sep 25) | Q2 (Dec 25) | Q3 (Mar 26) | Q4 (Jun 26) |
|---|---|---|---|---|
| Revenue | 5,018 | 12,682 | 10,243 | 11,120 |
| Gross margin | 9.3% | 6.3% | 9.9% | 17.5% |
| Operating margin | 3.6% | 3.7% | 6.1% | 13.4% |
| Net income | 168 | 401 | 483 | 1,178 |
| Diluted EPS | $0.26 | $0.60 | $0.72 | $1.62 |
More than half of fiscal 2026 net income came in the fourth quarter, when gross margin jumped to 17.5% from 9.9% the quarter before. Management credits a richer mix of enterprise customers and wider adoption of DCBBS. For the full year, though, the 10-K says gross margin fell (to 10.8% from 11.1%) because of "competitive pricing to gain market share, change in product and customer mix, and higher manufacturing related expenses." A value investor should not extrapolate one strong quarter. The consensus behind our P/E projection already assumes as much: S&P Global's compiled estimates (via StockAnalysis) put fiscal 2027 gross margin at about 10.0%, well below Q4's level.
Bars: quarterly revenue and net income, US$ billions. Line: trailing P/E = closing share price at quarter-end ÷ trailing-12-month diluted EPS (sum of the last four quarters; fiscal Q4 derived as full-year minus nine-month figures). EPS and share counts are restated for the 10-for-1 stock split (October 2024), matching split-adjusted prices. Sources: Form 10-Q/10-K data via SEC XBRL company facts; Yahoo Finance price history. Hover over a quarter for exact values.
Total tangible book value, US$ billions = shareholders’ equity minus goodwill and other intangible assets, at quarter-end. SEC XBRL data show no goodwill or intangible assets on Super Micro’s balance sheet, so tangible book equals shareholders’ equity. The June 2026 total includes the $4.2bn of mandatory convertible preferred stock carried in equity; the per-share figure in the tooltip deducts it. Source: balance sheets in Forms 10-Q/10-K via SEC XBRL company facts. Hover over a quarter for the components and the value per share.
V.Cash Conversion & Earnings Quality
Source: SMCI Forms 10-K; FCF = operating cash flow − capex (Pathos calculation).
This is the crux of the value debate. SMCI's profits are real accounting profits, but they have been consumed by working capital as the company grows. In fiscal 2026 the cash flow statement shows inventories absorbing $8.88B and receivables $3.92B, partly offset by customer deposits (deferred revenue, +$1.88B) and payables (+$0.96B). Year-end inventory was $12.9B, about 135 days of cost of sales against 87 days a year earlier.
- Encouraging: operating cash flow turned positive in the fourth quarter (+$747M), and deferred revenue, which is cash received before delivery, rose to $2.61B (current plus non-current) from $0.73B.
- Cautionary: inventory write-downs were $188M in FY26 and $232M in FY25. Inventory valuation and revenue recognition are the auditor's two critical audit matters. A demand air-pocket after a heavy inventory build is a classic hardware risk.
- Stock compensation was $412M in FY26 (1.1% of revenue, about 18% of net income). We treat it as a real cost. Consensus EPS, which drives our P/E projection, is likely non-GAAP and excludes it; in fiscal 2026 GAAP EPS ($3.26) was about 10% below non-GAAP EPS ($3.63).
VI.Balance Sheet Strength
| US$ millions, at 30 Jun | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
| Cash & equivalents | 440 | 1,670 | 5,170 | 7,521 |
| Bank lines & term loans | 290 | 476 | 112 | 4,056 |
| Convertible notes (carrying) | — | 1,698 | 4,645 | 4,664 |
| Net cash / (net debt) | 150 | (504) | 412 | (1,199) |
| Mandatory conv. preferred (liq. pref.) | — | — | — | 4,313 |
| Accounts receivable | 1,148 | 2,737 | 2,204 | 6,125 |
| Days sales outstanding | 59 | 67 | 37 | 57 |
| Inventories | 1,446 | 4,333 | 4,680 | 12,896 |
| Days inventory (on cost of sales) | 90 | 122 | 87 | 135 |
| Working capital | 1,805 | 6,586 | 9,957 | 20,566 |
| Current ratio | 2.3× | 3.8× | 5.2× | 3.9× |
| SMCI stockholders' equity | 1,972 | 5,417 | 6,302 | 14,479 |
Liquidity looks adequate. Current assets are 3.9 times current liabilities, and management states its sources of funds are sufficient for the next twelve months. Fiscal 2026 interest expense of $195M was covered about 14 times by operating income. The structure has changed sharply, though. Principal debt now totals roughly $8.8B: $4.06B of bank facilities (JPMorgan revolver $2.0B, CTBC facilities $1.76B, other loans) at rates of 1.3%–5.7%, and $4.73B of convertible notes. On top of that sits $4.31B of preferred stock. About $2.04B of bank borrowings are due within a year. The balance sheet is sound only as long as inventory keeps converting to cash.
VII.Capital Allocation & Dilution
| Date | Transaction | Size | Price / terms |
|---|---|---|---|
| Dec 2023 | Common stock offering (23.2M new shares) | $583M net | $26.20 |
| Feb 2024 | 0% convertible notes due 2029 (amended Feb 2025 to 3.50% coupon) | $1,725M | Conv. $83.44 |
| Mar 2024 | Common stock offering (20.0M shares) | $1,732M net | $87.50 |
| Feb 2025 | 2.25% convertible notes due Jul 2028 | $700M | Conv. $61.06 |
| Jun 2025 | 0% convertible notes due 2030, with capped calls | $2,300M | Conv. $55.20 |
| Jun 2025 | Share repurchase (4.89M shares, with the 2030 notes) | $200M | $40.89 |
| Jun 2026 | Common stock offering (52.3M shares incl. option) | $1,407M net | $27.50 |
| Jun 2026 | 7.00% Series A mandatory convertible preferred (SMCIP) | $4,313M liq. | Converts ~1 Jun 2029 |
| Jun 2026 | At-the-market equity program established | Up to $1,250M | No sales by 30 Jun 2026 |
- Persistent dilution. Shares outstanding rose from 523.1M at FY2022 year-end to 656.9M at FY2026 year-end (+25.6%). Diluted weighted shares rose from 536.2M to 697.3M.
- More to come. The preferred stock converts in 2029 into 130.7M–156.8M common shares (30.3040–36.3640 shares per $1,000 of preference, depending on the price then), which is 20–24% of today's count. It carries a 7% dividend, about $302M a year, payable in cash or stock; the first ($14.7778 per preferred share) was declared in cash, payable 1 Sep 2026. The three convertible notes would add about 73.8M shares if converted, though today's price is below all three conversion prices and capped calls partly offset the 2029 and 2030 notes.
- Timing of capital decisions. The company sold stock at $26.20 (Dec 2023) and $27.50 (Jun 2026) and bought back stock at $40.89 (Jun 2025). Issuing $5.7B of equity-like securities near the lows is the opposite of what value investors want to see, though the working-capital needs of fiscal 2027 growth largely explain it. There is no standing buyback program, and there is a $1.25B at-the-market program that allows new share sales from July 2026. We could not verify whether any shares have been sold under it since 30 June 2026.
VIII.Five-Year P/E Projection (Illustrative)
Method. We take fiscal 2027 and fiscal 2028 consensus EPS as Years 1 and 2 in every scenario, then apply stated growth rates for Years 3–5 and an exit P/E to Year-5 (fiscal 2031) EPS. The bear and bull cases are the low and high ends of our best-estimate assumptions; the base case is the midpoint. Year-5 value = exit P/E × Year-5 EPS, and present value = Year-5 value ÷ 1.105. Only then do we bring in today's price, to show the implied annual return = (Year-5 value ÷ price)1/5 − 1. A price move changes the implied return, not the value; the values change when consensus or the stated assumptions do.
| Input | Value | Type and basis |
|---|---|---|
| Share price | $26.87 | Source: Nasdaq close, 13 Nov 2026 |
| Year 0: FY2026 EPS | $3.63 non-GAAP $3.26 GAAP | Source: company results (Section XIV). Non-GAAP shown because consensus is on that basis |
| Trailing P/E | 7.4× 8.2× GAAP | Calculation: price ÷ FY2026 EPS. Shown for reference, not applied |
| Year 1: FY2027 consensus EPS | $6.52 | Source: Yahoo Finance, 18 analysts (range $6.19–$7.08), 15 Nov 2026 |
| Year 2: FY2028 consensus EPS | $6.95 | Source: Yahoo Finance, 18 analysts (range $5.39–$8.57); +6.6% on Year 1 |
| Today's forward P/E (context only) | 4.1× | Calculation: price ÷ Year-1 consensus EPS (the fiscal year already under way). Not used for the Year-5 value |
| Analysts' 5-year EPS growth (context) | 19.2% a year | Source: Finviz "EPS next 5Y", 31 Oct 2026. Not used directly |
| EPS growth, past 5 years | 73% a year (5-yr, Finviz) | Source: Finviz "EPS past 5Y". Not used: the jump from a small base will not repeat |
| EPS growth, Years 3–5 | Bear +5% · Base +8.7% · Bull +12% | Assumption: 5–12% a year after FY2028: revenue rides AI-server demand, but a thin-margin assembler facing strong competitors sees EPS lag revenue. |
| Exit P/E on Year-5 EPS | Bear 10.0× · Base 11.8× · Bull 14.0× | Assumption: 10–14×: a history of accounting and governance issues and a commoditising hardware business. Base = midpoint |
| Required return (present value) | 10% a year | Assumption |
How the range is built. Growth after the consensus years. 5–12% a year after FY2028: revenue rides AI-server demand, but a thin-margin assembler facing strong competitors sees EPS lag revenue. Exit multiple. 10–14×: a history of accounting and governance issues and a commoditising hardware business. The base case is the midpoint of that range: its implied annual return is exactly halfway between the bear and bull returns, and its exit multiple is the midpoint of the two multiples (base growth is solved to match). None of these values uses today's price: the price enters only the implied return, so a price move changes the return, not the value. For context, the shares trade at 4.1× the current-year consensus today.
Year-by-year EPS
| US$ per share | Y0 FY2026A | Y1 FY2027E | Y2 FY2028E | Y3 FY2029E | Y4 FY2030E | Y5 FY2031E |
|---|---|---|---|---|---|---|
| Bear EPS | $3.63 | $6.52 | $6.95 | $7.30 | $7.66 | $8.05 |
| Base EPS | $3.63 | $6.52 | $6.95 | $7.55 | $8.21 | $8.93 |
| Bull EPS | $3.63 | $6.52 | $6.95 | $7.78 | $8.72 | $9.76 |
| Growth, Years 1–2 (consensus) | +80% | +7% | ||||
| Growth, Years 3–5 | Bear +5% · Base +8.7% · Bull +12% | |||||
Year-5 value and implied return
| US$ | Bear | Base | Bull |
|---|---|---|---|
| EPS growth, Years 3–5 (a year, average) | +5.0% | +8.7% | +12.0% |
| Year-5 EPS (FY2031) | $8.05 | $8.93 | $9.76 |
| Exit P/E | 10.0× | 11.8× | 14.0× |
| Year-5 value | $80.45 | $105.61 | $136.70 |
| vs. today's price of $26.87 | +199% | +293% | +409% |
| Implied annual return (5-yr CAGR) | +24.5% | +31.5% | +38.5% |
| Present value at 10% a year | $49.96 | $65.58 | $84.88 |
| Present value vs. today's price | +86% | +144% | +216% |
IX.Return vs. Today's Price
Pathos illustrative Year-5 (fiscal 2031) value range (bear–bull ends of our assumptions, base = midpoint), with each scenario's implied annual return from today's price. Red line: today's price. Dashed green line: the base-case Year-5 value discounted at 10% a year.
At $26.87 the base case implies about +31.5% a year over five years (+24.5% bear, +38.5% bull), before any dividend. Discounted at a 10% required return, the base Year-5 value is worth $65.58 today, +144% versus the price. Put the other way: at the base exit P/E of 11.8×, a 10% annual return needs Year-5 EPS of about $3.66; EPS could fall about 19.3% a year in Years 3–5 and still deliver it. Evidence grade: Weak–moderate.
X.Superinvestor Holders (Dataroma)
Which of the portfolio managers that Dataroma tracks own SMCI, according to their latest 13F filings? The figures below come only from Dataroma’s SMCI ownership page and activity page.
Source: Dataroma · retrieved 15 Nov 2026 · 13F period Q2 2026 (holdings at 30 Jun 2026)XI.Key Risks for Value Investors
Accounting and governance history
The record is long, and the two most recent episodes are resolved only in part.
- Aug 2020: SEC charged SMCI with prematurely recognizing revenue and understating expenses over FY2015–FY2017. The company paid a $17.5M penalty without admitting or denying the findings, and the CEO reimbursed $2.1M in stock-sale profits.
- 27 Aug 2024: A short seller (Hindenburg Research; see Reuters coverage in Section XIV) alleged accounting manipulation, self-dealing and sanctions evasion. The company called the report false or inaccurate.
- 28–30 Aug 2024: SMCI delayed its FY2024 10-K and filed a notice of late filing (Form 12b-25). Nasdaq sent a non-compliance notice on 17 Sep 2024.
- 24 Oct 2024: Ernst & Young resigned as auditor during its first audit. Its letter cited information that had "led us to no longer be able to rely on management's and the Audit Committee's representations." The company said it disagreed with the decision.
- 18 Nov 2024: BDO USA was appointed as auditor, and a compliance plan was submitted to Nasdaq.
- 2 Dec 2024: A Special Committee (with Cooley LLP and Secretariat Advisors) found no substantial concerns about the integrity of senior management or the Audit Committee. It recommended a new CFO and a Chief Accounting Officer, and the Board adopted all recommendations.
- 25 Feb 2025: The FY2024 10-K and two delayed 10-Qs were filed, and Nasdaq confirmed compliance. Annual results for FY2022–FY2023 were not restated; they match the originally filed figures.
- FY2026 10-K (Aug 2026): Three previously reported material weaknesses were remediated. One IT-general-controls material weakness remains, so internal control over financial reporting was not effective at 30 June 2026. BDO nonetheless issued an audit opinion on the financial statements. The 10-K also lists David Weigand as CFO, the role the Special Committee recommended refilling.
Export-control investigations
On 19 March 2026 federal prosecutors in the Southern District of New York unsealed an indictment of three individuals employed by or associated with the company, including former SVP and director Yih-Shyan (Wally) Liaw, for an alleged conspiracy to violate export controls. SMCI is not a defendant. An independent Board investigation (Munger, Tolles & Olson with AlixPartners) found no evidence that current senior management knew of the alleged diversion, and no basis to conclude prior financial statements are unreliable. SEC, grand-jury, DOJ and Commerce Department (BIS) inquiries remain open and could lead to penalties or remediation requirements.
Cash conversion and inventory
Five-year cumulative free cash flow is −$7.9B against $5.4B of net income. Inventory stood at $12.9B at year-end. If AI demand pauses, or a new GPU generation makes stock obsolete, write-downs and discounting could erase much of a year's earnings.
Margin pressure and competition
Gross margin has fallen from 18.0% (FY23) to 10.8% (FY26), which the company attributes partly to pricing to win share. Dell, HPE, Lenovo and low-cost ODMs such as Foxconn and Quanta compete for the same AI build-outs. The consensus earnings in our projection depend on the Q4 FY26 margin improvement holding in part.
Customer concentration
One customer was 28.1% of FY26 sales. In FY25 four customers were each 11%–21%. At 30 June 2026, three customers made up 23.0%, 17.1% and 12.5% of receivables. Losing or delaying a single hyperscale or "neocloud" program could swing results.
Dependence on one supplier (NVIDIA, by inference)
One supplier provided 63.1% of FY26 purchases. Allocation, pricing or product-timing decisions by that supplier, as well as component shortages (the 10-K cites memory, storage, GPUs and CPUs), directly limit SMCI's revenue and margins.
Dilution and capital structure
About 131M–157M shares are due from the preferred in 2029, up to about 74M more if the notes convert, a $1.25B at-the-market program and about $412M a year of stock compensation. Per-share value can lag company-level growth.
Cyclicality and forecast risk
FY2027 guidance implies 66%–84% revenue growth, driven by AI data-center spending that may not stay linear. Our projection takes the fiscal 2027–28 consensus at face value; a revenue miss or a down year would leave Year-5 EPS well below even our bear case, which still assumes 5% annual growth after fiscal 2028.
XII.Advice to Management
Pathos's long-term owner principles judge management by the per-share value it builds over many years, not by quarterly results. Applied to SMCI's figures in this note, we would offer the following recommendations.
Rebuild trust with conservative accounting and full candour
The record includes a 2020 SEC accounting settlement, Ernst & Young's 2024 resignation citing an inability to rely on management's and the audit committee's representations, and one material weakness in IT controls still unremediated at 30 June 2026. We would close the remaining weakness quickly, have the audit committee ask the auditor each year whether it would have prepared the accounts differently and report the answer, and lead with GAAP figures (fiscal 2026 GAAP EPS of $3.26 was about 10% below non-GAAP).
Stop selling shares below their value
SMCI sold stock at $26.20 in December 2023 and $27.50 in June 2026 but bought it back at $40.89 in June 2025; shares outstanding rose 25.6% from fiscal 2022, the mandatory convertible preferred will add 130.7–156.8 million more in 2029, and a $1.25 billion at-the-market program is in place. Issuing shares cheaply and repurchasing them dearly is the reverse of good capital allocation. We would issue equity only when the price reflects intrinsic value and leave the at-the-market program unused at today's prices.
Make cash conversion the primary goal
Over five years SMCI reported $5.36 billion of net income but −$7.91 billion of free cash flow, and inventory reached $12.9 billion, about 135 days of cost of sales. Revenue guidance of $65–72 billion for fiscal 2027 will need more working capital. We would set public targets for inventory and receivable days and grow only as fast as the business can fund from its own cash.
Tie pay to free cash flow and return on capital
Stock compensation was $412 million in fiscal 2026, about 18% of net income. Pay that rewards revenue growth alone encourages the inventory build that has consumed the company's cash. We would base executive incentives on free cash flow and return on invested capital, with a charge for the capital each business uses.
Limit leverage while working capital is rising
Principal debt is roughly $8.8 billion, with about $2.04 billion of bank borrowings due within a year, plus $4.31 billion of preferred stock. The balance sheet is sound only while inventory turns into cash. We would set a ceiling on borrowing relative to cash flow and fund growth with internally generated cash rather than new layers of debt and preferred stock.
Strengthen compliance and board oversight
Three individuals associated with the company were indicted in 2026 on export-control charges. For a company that ships high-value AI systems worldwide, compliance failures can threaten customer relationships and licences. We would give the board an independent compliance committee and report its findings to shareholders each year.
Opinion, not advice. These recommendations are Pathos's opinion, based on long-term owner principles and the figures in this note; they are not investment advice.
XIII.Conclusion
The case for. SMCI is a genuine beneficiary of AI infrastructure spending. Revenue has grown more than sevenfold since FY2022, management guides to another $65–72B year, and the fourth quarter showed margins can improve with mix. At about 4.1× forward consensus earnings and 0.45× sales it is not priced like a typical AI winner. Its accounts are current and audited, the late-filing episode is resolved, and three of four material weaknesses have been fixed.
The case against. Earnings have not reached shareholders as cash. Free cash flow has been negative in three of the last five years, and cumulatively deeply negative. The share count keeps rising, and the company has repeatedly raised equity at low prices. Margins are thin and contested, a single customer and a single supplier dominate, and regulatory investigations remain open.
Pathos view (illustrative). On our best-estimate assumptions the base case implies about +31.5% a year (Year-5 range $80–$137) and is worth about $65.58 today at a 10% required return. Evidence: Weak–moderate. The FY2028 consensus range is wide ($5.39–$8.57), and most of the return comes from a low starting multiple. Points worth watching: (a) gross-margin compression, (b) governance and internal-control history, (c) lumpy GPU allocation and customer concentration. This is an educational illustration, not a recommendation to buy, sell or hold.
XIV.Sources & Notes
As-of dates. Share price, market capitalisation and all price-based multiples use the Nasdaq closing price of $26.87 on 13 November 2026. The 52-week range, analyst consensus and analysts' long-term growth estimate are as retrieved on 15 November 2026. Fundamentals are from the FY2026 Form 10-K (period ended 30 June 2026, filed 31 August 2026) unless stated. Ratios, free cash flow, days metrics and all projection outputs are Pathos calculations.
- Super Micro Computer, Inc., Form 10-K for fiscal year ended 30 June 2026 (filed 31 Aug 2026): financial statements, Notes 8, 9, 13, customer and supplier concentration, legal proceedings, Item 9A controls.
- "Supermicro Announces Fourth Quarter and Full Fiscal Year 2026 Financial Results", Exhibit 99.1 to Form 8-K (11 Aug 2026): Q4 figures, non-GAAP reconciliations, adjusted EBITDA, Q1 and FY2027 guidance.
- Form 10-K for fiscal year ended 30 June 2025 (filed 28 Aug 2025): FY2023–FY2025 figures and FY2024 balance sheet.
- Form 10-K for fiscal year ended 30 June 2024 (filed 25 Feb 2025): FY2022 split-adjusted figures.
- Forms 10-Q for Q1 FY26, Q2 FY26 and Q3 FY26: quarterly results.
- SEC EDGAR XBRL company facts for CIK 1375365: cross-check of annual and quarterly values and of FY2022–FY2023 balances.
- Form 8-K filings: 28 Aug 2024 (late 10-K), 20 Sep 2024 (Nasdaq notice), 30 Oct 2024 (EY resignation), 18 Nov 2024 (BDO appointment), 2 Dec 2024 (Special Committee findings), 26 Feb 2025 (Nasdaq compliance regained), 5 Aug 2026 (preferred dividend).
- U.S. SEC, "SEC Charges Super Micro and Former CFO in Connection with Widespread Accounting Violations", press release 2020-190 (25 Aug 2020).
- Yahoo Finance, SMCI price history and analyst estimates (retrieved 15 Nov 2026): 13 Nov 2026 close ($26.87), 52-week range, FY2027 consensus EPS $6.52 (18 analysts) and FY2028 $6.95 (17 analysts), mean price target $43.27 (15 analysts), beta.
- Reuters, "Hindenburg takes aim at AI server maker Super Micro with short position" (27 Aug 2024): identifies the short seller behind the report described in the 10-K.
- Finviz, SMCI quote and statistics (retrieved 31 Oct 2026): analysts' five-year EPS growth estimate ("EPS next 5Y", 19.17% a year), past five-year EPS growth, and corroboration of the $26.87 close.
- StockAnalysis, SMCI forecast (retrieved 15 Oct 2026; data from S&P Global Market Intelligence): FY2027 consensus EPS of $4.34 at that date, and the consensus FY2027 gross margin (9.96%).
- 24/7 Wall St., "The SMCI Number I'm Watching…" (18 Sep 2026): FY2027 consensus 30 days earlier ($3.35).
- SEC XBRL company facts (SEC EDGAR XBRL API, retrieved 15 Nov 2026): quarterly revenue, net income and diluted EPS from Forms 10-Q and 10-K (fiscal Q4 derived as full year minus nine months), and quarter-end equity, goodwill, intangible assets, preferred stock and shares outstanding. Used for the quarterly charts in Section IV.
- Yahoo Finance, SMCI daily price history (retrieved 15 Nov 2026): split-adjusted quarter-end closing prices for the trailing P/E line.
- Dataroma, SMCI superinvestor ownership page and activity page (retrieved 15 Nov 2026): ownership count, rank, % of all portfolios, hold price, holders, % of portfolio, shares, value and recent activity for 13F period Q2 2026 (holdings at 30 Jun 2026). 13F data are filed up to 45 days after quarter-end and cover long US-listed positions only.
Not verified or not used: share sales under the at-the-market program after 30 June 2026 (none disclosed as of the 10-K cover date); the name of the 63.1% supplier (not disclosed); the identity of the 28.1% customer (not disclosed); outstanding options and RSUs beyond what the diluted share counts capture; FY2027 first-quarter results (the quarter ends 30 Sep 2026 and has not been reported). Analysts' five-year growth estimates come from a single aggregator (Finviz) and are not audited. The P/E projection's calculations are kept with the site files (model/pe_projection.py) for audit.